South San Francisco, California-based 23andMe filed for bankruptcy last month, seeking to sell its business at auction after ...

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices ...

Pharmaceutical giant Regeneron has emerged as the winning bidder for consumer genetics company 23andMe in a court-supervised ...

The new owner, Regeneron Pharmaceuticals intends to continue providing 23andMe’s consumer genome services, it said.

Regeneron Pharmaceuticals is acquiring the assets of 23andMe for $256 million, excluding its Lemonaid Health business, as the ...

Investors burned by President Trump’s trade fight now have to contend with a spending megabill that risks swelling the ...

Clothing company Levi Strauss announced Tuesday it will sell its Dockers line to Authentic Brands Group in a more than $300 ...

CBS News President Wendy McMahon announced Monday her resignation as network head amid an ongoing lawsuit with the network ...

Wall Street indices closed mixed on Monday. Moody's downgraded the U.S. credit rating due to rising debt. S&P 500 marked its ...

The U.S. Food and Drug Administration (FDA) is set to significantly alter its approach to approving COVID-19 vaccines, a move ...

Uh-oh. We’re in conference hell, one of those periods of the year when tech companies try to seize control of the news cycle ...

Regeneron Pharmaceuticals said it would acquire 23andMe, which filed for bankruptcy in March and would continue to offer ...